News    

Phacilitate 2020

Description

CellCAN attended Phacilitate Leaders World Summit 2020 CellCAN spent an exciting week in Miami for the 2020 Phacilitate Leaders World summit. We attended talks, toured the exhibit hall, and met with cell and gene therapy manufacturers. The Canadian landscape was well represented, with representatives from Calgary, Toronto, Ottawa, and Montreal. Since Phacilitate is run alongside the World Stem Cell Summit, we were treated to talks on the latest advances in the field, including treatments for...'

Details
  • 21/02/2020

Hosting a GMP Workshop

Description

Foundational knowledge in GMP Manufacturing - Hands-on Workshop WHY THIS WORKSHOP? The number of good manufacturing practice (GMP) facilities is growing in Canada with the rapid progressions in cell & gene therapy (CGT). This has created a need for well-trained highly qualified personnel (HQP), as working under GMP conditions and requirements for GMP manipulations are regulated and quite different than in standard research laboratories.  For this reason, CellCAN has been offering s...'

Details
  • 17/01/2020

Strategic Recognition for Cell Therapy in Quebec and Canada

Description

The Government of Quebec announced this morning the designation of the University Institute of Hemato-Oncology and Cell Therapy at Maisonneuve-Rosemont Hospital, part of the CIUSSS-de-l'Est-de-l'Île-de-Montréal. This appointment confirms the expertise and experience of the clinicians and researchers at Hôpital-Maisonneuve Rosemont (HMR), and positions this institution as the hub for the development of cell therapy in Quebec, and more broadly in Canada and around the world. ...'

Details
  • 21/10/2019

CTSG April 2019 Update

Description

CTSG April 2019 Update - We had our bi-annual Cell Therapy Stakeholder Group (CTSG) meeting with Health Canada on April 30, 2019. 9 Agenda items were presented and discussed at this meeting. Approved meeting minutes are available here.   1) The first agenda item included a welcome, roundtable and announcements of retirements and new appointments. Cathy Parker co-chair of the CTSG group and Director General of BGTD had retired in December 2018. Dr. Celia Lourenco took up this role ...'

Details
  • 17/09/2019

News from our Network

Description

CELLCAN WELCOMES NEW TEAM MEMBERS We want to wish Helen Yu and Leah Kesselman a warm welcome to the CellCAN team as our two new Scientific Knowledge Managers. Helen and Leah are joining the team to further support the knowledge mobilization efforts of the Network and the broadening of our training offer in the following months.  BUILDING A STRONG CANADIAN NETWORK ...'

Details
  • 27/05/2019

Connect with a network of Canadian researchers, clinicians, regulatory experts and HQP from coast to coast, through our platforms, workshops and events.

13 NETWORK AFFILIATES. 25 PARTNER ORGANIZATIONS. 181 NETWORK COLLABORATORS.